SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (671)9/25/2000 1:18:22 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 810
 
Can't believe what a POLUTED this board was/is (last two days).

I am following ONXX (without position) from 96, when they first time presented early PI X-015 clinical data at ASCO (LA). They did cure some of the pts (H&N cancer). Color picture of pts (before and after treatment) were visible and very clear from far distance. Also, I was/am very positive surprised with WL/PFE commitment to this drug.

However, I will not make my move until RAF-program give early sign of possible success.

Miljenko



To: Larry Liebman who wrote (671)9/25/2000 8:32:03 PM
From: johnsto1  Respond to of 810
 
Thanks,
Larry Liebman and Richard Harmon for your knowledgeable, informative addition to the ONXX thread. Much appreciated.

j1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News